Paolo Bruno

Paolo Bruno is a skilled scientist with extensive experience in medicinal chemistry and drug design. Currently, Paolo Bruno coordinates medicinal chemistry activities at Chiesi Group, focusing on discovery projects for respiratory diseases and contributing to the identification of CHF-6523. Prior to this role, Paolo Bruno worked as a Research Specialist at Aptuit, designing synthetic routes and synthesizing compound libraries for pharmaceutical clients. Earlier experience includes a postdoctoral research position at IRB Barcelona, where Paolo Bruno investigated the total synthesis of thiopeptide antibiotics and co-authored four peer-reviewed publications. Educational qualifications include a PhD in Organic Chemistry from Università di Pavia and a Master's degree in Organic Chemistry from the same institution, along with coursework at the University of Oregon.